Lowes, D. J., Hevener, K. E., & Peters, B. M. (2020). Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome. Antimicrob Agents Chemother.
Chicago Style CitationLowes, David J., Kirk E. Hevener, and Brian M. Peters. "Second-Generation Antidiabetic Sulfonylureas Inhibit Candida Albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome." Antimicrob Agents Chemother 2020.
MLA CitationLowes, David J., Kirk E. Hevener, and Brian M. Peters. "Second-Generation Antidiabetic Sulfonylureas Inhibit Candida Albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome." Antimicrob Agents Chemother 2020.
Warning: These citations may not always be 100% accurate.